Study of the Analgesic Effect of the Perineal Infiltration of Ropivacaine 0.75% Versus Placebo in Post-episiotomy Perineal Pain (ROPISIO)
Study of the Analgesic Effect of the Perineal Infiltration of Ropivacaine 0.75% Versus Placebo in Post-episiotomy Perineal Pain: a Randomized, Double-blind Study
Sponsor: Centre Hospitalier Departemental Vendee
This PHASE3 trial investigates Episiotomy and is currently completed. Centre Hospitalier Departemental Vendee leads this study, which shows 13 recorded versions since 2017 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
13 versions recorded-
Dec 2025 — Present [monthly]
Completed PHASE3
-
Sep 2025 — Dec 2025 [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2022 — Jul 2024 [monthly]
Completed PHASE3
▶ Show 8 earlier versions
-
Feb 2021 — Jan 2022 [monthly]
Completed PHASE3
Status: Recruiting → Completed
-
Jan 2021 — Feb 2021 [monthly]
Recruiting PHASE3
-
Feb 2020 — Jan 2021 [monthly]
Recruiting PHASE3
-
Jan 2019 — Feb 2020 [monthly]
Recruiting PHASE3
-
Jun 2018 — Jan 2019 [monthly]
Recruiting PHASE3
-
Nov 2017 — Jun 2018 [monthly]
Recruiting PHASE3
-
Oct 2017 — Nov 2017 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
-
Apr 2017 — Oct 2017 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Centre Hospitalier Departemental Vendee
For direct contact, visit the study record on ClinicalTrials.gov .